Promiscuous survivin peptide induces robust CD4+T-cell responses in the majority of vaccinated cancer patients

DSpace Repository

Promiscuous survivin peptide induces robust CD4+T-cell responses in the majority of vaccinated cancer patients

Author: Widenmeyer, Melanie; Griesemann, Heinrich; Stevanovic, Stefan; Feyerabend, Susan; Klein, Reinhild; Attig, Sebastian; Hennenlotter, Joerg; Wernet, Dorothee; Kuprash, Dmitri V.; Sazykin, Alexei Y.; Pascolo, Steve; Stenzl, Arnulf; Gouttefangeas, Cecile; Rammensee, Hans-Georg
Tübinger Autor(en):
Widenmeyer, Melanie
Griesemann, Heinrich
Stevanović, Stefan
Feyerabend, Susan
Klein, Reinhild
Attig, Sebastian
Hennenlotter, Jörg
Wernet, Dorothee
Pascolo, Steve
Stenzl, Arnulf
Gouttefangeas, Cécile
Rammensee, Hans-Georg
Published in: International Journal of Cancer (2012), Bd. 131, H. 1, S. 140-149
Verlagsangabe: Wiley - Blackwell
Language: English
Full text: http://dx.doi.org/10.1002/ijc.26365
ISSN: 0020-7136
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)